The onset of NAFLD generally begins with abnormal fat accumulation in hepatocytes, where a large amount of FFAs derived from either excess dietary lipids or increased lipolysis in adipose tissue enter via fatty acid translocase (FAT/CD36) [74]. Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.